Tag Archives: Acetylcholinesterase Inhibitors

Review of Interventions Which May Potentially Delay Functional Decline in Persons With Dementia (BMJ Open)

Summary The authors examined 23 systematic reviews about the benefits of non-pharmacological, pharmacological and alternative therapies on activities of daily living (ADL) in people with dementia. Interventions thought to be effective (based on evidence sometimes judged to be “low quality”) … Continue reading

Posted in Commissioning, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), Integrated Care, International, Management of Condition, Models of Dementia Care, Non-Pharmacological Treatments, Person-Centred Care, Personalisation, Pharmacological Treatments, Quick Insights, Systematic Reviews, Universal Interest | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Assessment and Treatment of Dementia in Older Adults (NICE Eyes on Evidence)

Summary A quick review of the latest evidence regarding the assessment and treatment of dementia in older adults. This systematic review indicates that brief cognitive assessment tools can adequately detect early dementia. Whether interventions for mild cognitive impairment or early dementia … Continue reading

Posted in Diagnosis, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Management of Condition, Models of Dementia Care, NICE Guidelines, Non-Pharmacological Treatments, Patient Care Pathway, Pharmacological Treatments, Quick Insights, Systematic Reviews, UK, Universal Interest | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Use of NICE Appraised Medicines in the NHS in England (HSCIC)

Summary The Health and Social Care Information Centre (HSCIC) estimates that national figures for Alzheimer’s Disease medicine use have been underestimated by around five per cent. Section 3.1 in this report relates to Alzheimer’s Disease medicines: donepezil, galantamine, rivastigmine and memantine. … Continue reading

Posted in For Doctors (mostly), For Researchers (mostly), National, NHS, Pharmacological Treatments, Quick Insights, Statistics, UK, Universal Interest | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Antipsychotic Prescribing for Dementia Patients Declines in UK (BMJ Open)

Summary A cohort study into the pattern and trends in the use of antipsychotics and antidepressants etc. in Alzheimer’s Disease and other dementias has discovered that antipsychotic prescribing by GPs did fall markedly from 20% in 1995 to around 7% … Continue reading

Posted in Antipsychotics, Community Care, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), Management of Condition, Mental Health, National, NHS, Pharmacological Treatments, Quick Insights, UK, Universal Interest | Tagged , , , , , , , , , , , , , , , , , , | Leave a comment